$BDRX News

Biodexa issues letter to Shareholders

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Why Is Biodexa Pharmaceuticals (BDRX) Stock Skyrocketing Today?

Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies

Biodexa Pharmaceuticals shares are trading higher after the company announced a partnership with Syngene International for the manufacture of both MTX240 active pharmaceutical ingredient and dosage form.

Biodexa Pharmaceuticals Shares Resume Trade

Biodexa Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 70.03%

Biodexa Pharma Partners With Syngene International To Manufacture Both MTX240 Active Pharmaceutical Ingredient And Dosage Form

BDRX: Initiating Coverage of Biodexa Pharmaceuticals; A Deep Value Oncology Platform Built Around Two High-Conviction Areas

Preliminary Results for the Year Ended 31 December 2025

Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group

Biodexa Pharma Enters Into Strategic Partnership With Tanner Pharma Group To Make eRapa Available For FAP Patients Via Early Access Program And Named Patient Prescribing

Biodexa Pharmaceuticals To Implement 1-For-5 Reverse ADR Split, Changing ADR Ratio From 1:100,000 To 1:500,000 Ordinary Shares Effective April 6, 2026

Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer

Biodexa Pharmaceuticals Adds New Phase 1 Ready Candidate To Its Portfolio To Treat Gastrointestinal Stromal Tumors

Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

Biodexa Licenses Otsuka Molecular Glue OPB-171775 For GIST, Plans Phase 1-Ready Candidate MTX240 With Global Rights Ex-Japan

Biodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary